MAPT and Alzheimer disease: Feature selection demonstrated that across the entire cohort, core Alzheimer’s disease pathology markers (e.g. CSF measures of pT217/T217, pT111/T111 and p-tau/Aβ40lumi) were the strongest predictors of a positive amyloid PET scan.